Abstract
Malignant recurrence always presents as a unique therapeutic challenge, more so in the setting of prior radiation. Where re-irradiation is considered, striking a delicate balance between avoiding normal tissue toxicity while still delivering sufficient doses to the recurrence is ideal. For this purpose, with its capacity to deliver ablative doses to the tumor target in a highly conformal manner, stereotactic body radiation therapy (SBRT) proves to be an attractive option. What follows is a case of a locally advanced cervical cancer patient who underwent concurrent chemoradiotherapy but who, a year after treatment, presented with an isolated pelvic lymph node recurrence within the prior radiation field. SBRT re-irradiation to the oligo-recurrence was subsequently performed.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
